ArticleSignal transduction and targeted therapy2024

Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis.

Lin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.